The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading higher by 18 points at 25,526, indicating that the domestic benchmark indices are likely to make a positive start on Friday.
Earlier on Thursday, 3 July, the Domestic benchmark indices S&P BSE Sensex slumped by 170 points or 0.20%, and settled at 83,240, while the Nifty50 traded 0.19% lower or 48 points, closing at 25,405.
Here are some stocks that are likely to remain in focus on 4 July.
Reliance Industries: RRVL made a strategic minority investment in UK-based FACEGYM—a pioneer in facial fitness and skincare, underscoring its expansion into the high-growth beauty and wellness sector.
Oil and Natural Gas Corporation: ONGC signed a Heads of Agreement with Japan’s Mitsui O.S.K. Lines under which Mitsui will build, own, and operate two Very Large Ethane Carriers (VLECs) for ONGC’s ethane imports. ONGC noted in an exchange filing that the deal awaits approval from its Board of Directors.
Godavari Biorefineries: Godavari Biorefineries secured a European patent for its novel anticancer molecule. The patent, now validated in Spain, the UK, and as a Unitary Patent, covers a highly potent compound proven effective against cancer cells and cancer stem cells.
Piramal Pharma: Carlyle Group intends to divest up to 10% of Piramal Pharma through block trades, which could raise about Rs 2,600–2,700 crore. Carlyle’s stake in Piramal stood at 18% as of March 2025.
Emcure Pharmaceuticals: BC Investments IV (a Bain Capital fund) plans to sell approximately 2.4% of Emcure Pharmaceuticals via block deals worth around Rs 551 crore. As of March 2025, BC Investments IV held an 8.68% stake in Emcure.
Aegis Logistics: Aegis Logistics commissioned a new liquefied petroleum gas (LPG) cryogenic terminal at Pipavav, providing 48,000 MT of static storage capacity for LPG handling and distribution.
Arkade Developers: The company has inked a binding agreement to acquire an entire stake in Filistan for Rs 183 crore, giving the company access to the iconic 4-acre land parcel in Goregaon West, which is also called Filmistan Studios.
Torrent Pharma: The company has announced signing a share purchase agreement for acquiring an additional 2.1% stake in JB Chemicals and Pharmaceuticals Ltd for a total consideration of Rs 1,600 crore.
The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!
